, /PRNewswire/ -- The (JCC) is a leader in biomedical research funding, having committed more than together with its partners. For nearly eighty years, JCC has supported groundbreaking science by the most promising postdoctoral fellows in cancer and human disease research. The esteemed Board of Science Advisors selected twenty-six new fellows from one of the largest applicant pools in the fund's history based on their doctoral research accomplishments, innovative research plans, and their chosen scientific mentors.
Awardees are conducting research in a broad range of biomedical disciplines, from unveiling novel therapeutic targets in cancer to understanding the complex neurological mechanisms required for an animal to weigh behavioral instinct against learned experience. "The Jane Coffin Childs Fund has a long history of funding innovative science that spans all areas of biology. We are proud to be able to support this new cohort of outstanding postdoctoral fellows who have made important contributions during graduate school and developed exciting new directions to pursue as postdoctoral fellows," said Sue Biggins, Ph.
D., chair of the JCC's Scientific Advisory Board "Our experience has demonstrated that support from JCC will catalyze the careers of our fellows and lead to major scientific breakthroughs." Biggins is an Investigator with the Howard Hughes Medical Institute (HHMI) and Director of the Basic Sciences Division of the Fred Hutch in , as well as a former JCC Fellow.
.
